Sentinel node biopsy for melanoma: Unnecessary treatment?

BMJ (Online)

Volumn 346, Issue 7890, 2013, Pages

  Torjesen, Ingrid ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; CELLULITIS; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; HEALTH CARE SYSTEM; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MELANOMA; NATIONAL HEALTH SERVICE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SENTINEL LYMPH NODE BIOPSY; UNITED KINGDOM; UNITED STATES; WOUND INFECTION;

EID: 84872300546     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e8645     Document Type: Review

References (24)

1. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-17. (Pubitemid 44465459)
2. Cancer Research UK. Cancer incidence statistics. www.cancerresearchuk. org/cancer-info/cancerstats/types/skin/incidence/uk-skin-cancer-incidence- statistics.
3. Skin Cancer Foundation. Skin cancer facts. www.skincancer.org/skin- cancer-information/skin-cancer-facts.
4. National Institute for Health and Clinical Excellence. Improving outcomes for people with skin tumours including melanoma. 2006. www.nice.org.uk/ CSGSTIMhttp://www.nice.org.uk/nicemedia/pdf/CSG-Skin-Manual.pdf.
5. Morton D, Cagle L, Wong J. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. 42nd annual meeting of the Society of Surgical Oncology, Washington, DC, 20-22 May, 1990.
6. Morton DL, Wen D-R, Wong, JH, Economou JS, Cagle, LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
7. Morton DL, Cochran AJ. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol 2004;151:308-19. (Pubitemid 39215144)
8. Rosenberg SA. Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol 2008;5:1. (Pubitemid 351512418)
9. Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 2008;5:18-23. (Pubitemid 351512425)
10. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252:426-33.
11. Morton D, Thompson JF, Cochran AJ, Elashoff R. Sentinel node biopsy and immediate lymphadenectomy for occult metastases versus nodal observation and delayed lymphadenectomy for nodal recurrence: fourth interim analysis of MSLT-I. Ann Surg Oncol 2010;17(suppl 1):S22-3.
12. Morton DL. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 2012 Jun 24. Epub ahead of print.
13. Multicenter Selective Lymphadenectomy Trial. http://clinicaltrials.gov/ ct2/show/NCT00275496.
14. Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 2003;10:27-31.
15. Thomas JM. Sentinel node biopsy in melanoma: the gulf between presentation and reality. Skinmed 2010;8:222-4.
16. Campanholi LL, Duprat JP, Fregnani JHTG. Incidence of LE due to treating cutaneous melanoma. J Lymphoedema 2011;6:30-4.
17. Bilimoria KY, Balch CM, Bentrem DJ, Talamonti MS, Ko CY, Lange JR, et al. Complete lymph node dissection for sentinel node positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol 2008;15:1566-76.
18. Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005;23:6054-62.
19. Multicenter Selective Lymphadenectomy Trial II (MSLT-II). http://clinicaltrials.gov/ct2/show/NCT00297895.
20. Wong SL, Balch CM, Hurley P, Agarwala SS, Akhurst TJ, Cochran A, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. www.asco.org/guidelines/snbmelanoma.
21. Agnese DM, Abdessalam SF, Burak Jr WE, Magro CM, Pozderac RV, Walker MJ, et al. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003;134:542-8. (Pubitemid 37411959)
22. National Cancer Institute. Melanoma. www.cancer.gov/cancertopics/types/ melanoma.
23. Shamsian N, Hamilton S, Parikh A, Butler PEM. Electronic responses to: Surgical management of metastatic inguinal lymphadenopathy (BMJ 2004;329:1272). www.bmj.com/content/329/7477/1272?tab=responses.
24. Office for National Statistics. Cancer Registration Statistics, England 2000. ONS, 2003.